Clario Named Top-Tier Software Vendor by APPS RUN THE WORLD in the APPS TOP 500 Market Report

Clario Strengths, Domain Expertise, and Key Differentiators

Clario is a technology firm dedicated to advancing clinical research by merging scientific proficiency with global reach to develop the most comprehensive endpoint technology platform. Through this, Clario enables its collaborators to effect transformative changes in healthcare. Driven by a commitment to technological innovation, Clario aims to shape the future of clinical trials and contribute positively to global healthcare outcomes.

Clario Recent Developments

In 2025, Clario’s strategic collaboration with Amazon Web Services (AWS) marks a major evolution in its digital clinical trial ecosystem, positioning the company at the forefront of AI-driven innovation in life sciences. By leveraging AWS’s robust AI and machine learning infrastructure, Clario is developing a proprietary generative AI platform that orchestrates multiple large language and deep learning models to streamline clinical trial data processing.

Clario Mergers and Acquisitions (M&A) Activities

In 2025, Clario has acquired WCG’s electronic clinical outcome assessment (eCOA) business marks a strategically significant expansion in its neuroscience-focused capabilities, further solidifying its leadership in digital endpoint data solutions for clinical trials. This move, following the recent acquisition of NeuroRx, enhances Clario’s ability to deliver comprehensive, high-quality data across a full spectrum of neuroscience endpoints—from study design and site training to centralized imaging and cardiac safety. With seamless integration plans and continued support for ongoing trials, Clario is uniquely positioned to accelerate the development of breakthrough therapies in areas of high unmet medical need.

Clario Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying Clario applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of Clario and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified eCOA Clinical Trials, Clario Source Document Manager customers.

Clario Key Enterprise and Cloud Applications

eCOA Clinical Trials, Clario Source Document Manager

Clario Revenues, $M:

Clario Revenue Breakdown By Type, $M:

Clario Enterprise Applications Revenues By Functional Markets, $M:

Clario Enterprise Applications Revenues By Verticals, $M:

Clario Revenues By Region, $M

Clario Direct vs Indirect sales

Clario Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified Clario Customers

No. of Clario Customers: 770

No. of Clario Enterprise Applications Customers: x

No. of Clario Cloud Customers: x

No. of Clario Cloud Subscribers: x

Clario boasts a client base exceeding 770, inclusive of the top 20 pharmaceutical and biotech companies worldwide. Notable clients include Pfizer, ClinPlan, Millennium Pharmaceuticals, Luitpold Pharmaceuticals, and numerous others.

Clario Market Opportunities, M&A and Geo Expansions

The merger of ERT Clinical and BioClinica represents a fusion of decades of scientific expertise and unparalleled global reach, establishing Clario as a comprehensive endpoint technology platform. Positioned to streamline the clinical trial process, enhance trial experiences, and unlock composite endpoints, Clario transcends the mere amalgamation of two companies.

Clario Risks and Challenges

Clario disclosed the divestiture of its Software Solutions business, an all-encompassing offering designed to facilitate the clinical trial lifecycle. The suite, known as Clario eClinical (comprising CTMS, eConsent, EDC, RTSM/IRT, Patient, and Site Payments), will undergo rebranding and integration into the established Sitero Mentor platform. Sitero Mentor will continue to support the existing Clario customer base while further developing innovative Clinical solutions for new customers as well.

Heightened consolidation within the pharmaceutical industry may impede Clario's future growth trajectory. Moreover, shifts in senior leadership could prompt alterations in both product development strategies and business operations.

Clario Ecosystem, Partners, Resellers and SI

Clario cultivates diverse Strategic Partnerships aligned with our vision and best practices to address customer needs effectively. These partnerships encompass marketing, technical, and co-development collaborations aimed at achieving mutual objectives. Among Clario's Partners are AliveCor, Cogstate, ActiGraph, MedSource, MMS Holdings, PRL Central Laboratory Services, Health Sciences International, Novella Clinical, Axio Research, Beardsworth, Kaizen Clinical Services, Symbiance, and several others.

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: